Search Results - "Yaremko, L M"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Nonpalpable breast lesions: findings of stereotaxic needle-core biopsy and fine-needle aspiration cytology by Dowlatshahi, K, Yaremko, M L, Kluskens, L F, Jokich, P M

    Published in Radiology (01-12-1991)
    “…Two hundred fifty mammographically detected nonpalpable breast lesions suspicious for malignancy in women who underwent routine screening mammography were…”
    Get more information
    Journal Article
  2. 2

    Role of CD44 in nonpalpable T1a and T1b breast cancer by Lyzak, J.S, Yaremko, M.L, Recant, W, Baunoch, D.A, Joseph, L

    Published in Human pathology (01-07-1997)
    “…Primary infiltrating ductal carcinomas (IDCs) of the breast which measure less than 0.5 cm (T1a lesions) and between 0.5 and 1.0 cm (T1b lesions) are…”
    Get full text
    Journal Article
  3. 3

    Sequence identity locates CEBPD and FGFR1 to mapped human loci within proximal 8p by Wood, S, Schertzer, M, Yaremko, M L

    Published in Cytogenetics and cell genetics (01-01-1995)
    “…The gene loci for human CEBPD (CCAAT enhancer binding protein, delta chain) and FGFR1 (fibroblast growth factor receptor) have been identified within two…”
    Get more information
    Journal Article
  4. 4

    Immunomagnetic separation can enrich fixed solid tumors for epithelial cells by Yaremko, ML, Kelemen, PR, Kutza, C, Barker, D, Westbrook, CA

    Published in The American journal of pathology (01-01-1996)
    “…Immunomagnetic separation is a highly specific technique for the enrichment or isolation of cells from a variety of fresh tissues and microorganisms or…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Giant benign mesenchymoma of the breast by Klouda, M J, Yaremko, L M, Howeedy, A A, Staren, E D

    Published in Surgery (01-04-1991)
    “…The term mesenchymoma refers to a group of mixed tumors that are composed of two or more mesenchymal elements, excluding fibrous tissue, not ordinarily found…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer by Yaremko, M. Lisa, Kutza, Chris, Lyzak, Judy, Mick, Rosemarie, Recant, Wendy M., Westbrook, Carol A.

    Published in Genes chromosomes & cancer (01-07-1996)
    “…Loss of heterozygosity (LOH) from the short arm of chromosome 8 (8p) is frequent in many human cancers, including breast, colon, prostate, and bladder cancers…”
    Get full text
    Journal Article
  9. 9

    Appendiceal Kaposi's sarcoma: a cause of right lower quadrant pain in the acquired immune deficiency syndrome by Deziel, D J, Saclarides, T J, Marshall, J S, Yaremko, L M

    Published in The American journal of gastroenterology (01-07-1991)
    “…These case reports describe two patients with acquired immune deficiency syndrome (AIDS) who presented with acute right lower quadrant pain. Appendiceal…”
    Get more information
    Journal Article
  10. 10

    Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers by Yaremko, M L, Recant, W M, Westbrook, C A

    Published in Genes chromosomes & cancer (01-07-1995)
    “…Loss of heterozygosity (LOH) from the short arm of chromosome 8 (8p) is common to many human carcinomas, including those of the colon and prostate. It…”
    Get more information
    Journal Article
  11. 11

    Expression of a new mucin-type glycoprotein in select epithelial dysplasias and neoplasms detected immunocytochemically with Mab A-80 by Shin, S S, Gould, V E, Gould, J E, Warren, W H, Gould, K A, Yaremko, M L, Manderino, G L, Rittenhouse, H G, Tomita, J T, Jansson, D S

    “…We studied by immunocytochemistry 573 tissue and 106 cytologic samples of human tumors, non-neoplastic proliferative lesions and normal tissues with the…”
    Get more information
    Journal Article
  12. 12

    Loss of heterozygosity in 8p is associated with microinvasion in colorectal carcinoma by Kelemen, P R, Yaremko, M L, Kim, A H, Montag, A, Michelassi, F, Westbrook, C A

    Published in Genes chromosomes & cancer (01-11-1994)
    “…Loss of heterozygosity (LOH) from the short arm of chromosome 8 is frequent in a variety of malignancies, suggesting the presence of a tumor suppressor gene in…”
    Get more information
    Journal Article
  13. 13

    Mapping of the pulmonary surfactant SP5 (SFTP2) locus to 8p21 and characterization of a microsatellite repeat marker that shows frequent loss of heterozygosity in human carcinomas by Wood, S, Yaremko, M L, Schertzer, M, Kelemen, P R, Minna, J, Westbrook, C A

    Published in Genomics (San Diego, Calif.) (01-12-1994)
    “…We have identified 4 cosmids at the SFTP2 locus by cDNA hybridization. SFTP2 was mapped using a polymorphic CA repeat and localized to 8p21 by FISH. Allele…”
    Get more information
    Journal Article
  14. 14

    Identification of the human neuronal nicotinic cholinergic alpha 2 receptor locus, (CHRNA2), within an 8p21 mapped locus, by sequence homology with rat DNA by Wood, S, Schertzer, M, Yaremko, M L

    Published in Somatic cell and molecular genetics (01-03-1995)
    “…We have identified a cosmid, at the D8S131 locus, that shows sequence homology with exon 2 of the rat gene for the neuronal nicotinic acetylcholine receptor…”
    Get full text
    Journal Article
  15. 15

    Chromosome 17p allelic loss in colorectal carcinoma. Clinical significance by Takanishi, Jr, D M, Angriman, I, Yaremko, M L, Montag, A, Westbrook, C A, Michelassi, F

    Published in Archives of surgery (Chicago. 1960) (01-06-1995)
    “…To correlate allelic losses on chromosomes 5q, 8p, 17p, and 18q in colorectal adenocarcinomas with histopathologic features of known prognostic significance…”
    Get more information
    Journal Article
  16. 16

    Deletion mapping reveals two regions of chromosome 8 allele loss in colorectal carcinomas by Yaremko, M L, Wasylyshyn, M L, Paulus, K L, Michelassi, F, Westbrook, C A

    Published in Genes chromosomes & cancer (01-05-1994)
    “…Colorectal carcinogenesis is associated with the accumulation of genetic changes involving both dominant oncogenes and tumor suppressor genes. Although at…”
    Get more information
    Journal Article